Patents by Inventor Stefan G. Sarafianos

Stefan G. Sarafianos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of hepatitis B virus targeting capsid assembly
    Patent number: 10759774
    Abstract: The present invention provides novel compounds and methods for treating, preventing or inhibiting hepatitis B virus (HBV).
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: September 1, 2020
    Assignees: THE CURATORS OF THE UNIVERSITY OF MISSOURI, REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Stefan G. Sarafianos, Zhengqiang Wang, Andrew D. Huber, Jing Tang
  • INHIBITORS OF HEPATITIS B VIRUS TARGETING CAPSID ASSEMBLY
    Publication number: 20190092742
    Abstract: The present invention provides novel compounds and methods for treating, preventing or inhibiting hepatitis B virus (HBV).
    Type: Application
    Filed: September 27, 2018
    Publication date: March 28, 2019
    Applicants: THE CURATORS OF THE UNIVERSITY OF MISSOURI, Regents of the University of MInnesota
    Inventors: Stefan G. Sarafianos, Zhengqiang Wang, Andrew D. Huber, Jing Tang
  • Suppression of SARS replication by SARS helicase inhibitors
    Patent number: 9266844
    Abstract: The present invention relates to compounds, compositions, and methods, for treating subjects suspected of needing treatment for a Nidovirales virus infection. In certain embodiments, the compounds comprise Nidovirales helicase inhibitors that do not significantly affect helicase ATPase enzymatic activity or nucleic acid binding activity of the helicase.
    Type: Grant
    Filed: June 17, 2013
    Date of Patent: February 23, 2016
    Assignee: The Curators of the University of Missouri
    Inventors: Stefan G. Sarafianos, Adeyemi O. Adedeji, Kamlendra Singh
  • Suppression of Sars Replication by Sars Helicase Inhibitors
    Publication number: 20140005241
    Abstract: The present invention relates to compounds, compositions, and methods, for treating subjects suspected of needing treatment for a Nidovirales virus infection. In certain embodiments, the compounds comprise Nidovirales helicase inhibitors that do not significantly affect helicase ATPase enzymatic activity or nucleic acid binding activity of the helicase.
    Type: Application
    Filed: June 17, 2013
    Publication date: January 2, 2014
    Applicant: The Curators of the University of Missouri
    Inventors: Stefan G. Sarafianos, Adeyemi O. Adedeji, Kamlendra Singh